Answers are grounded in this paper and cite their sources.
Drug-resistant tuberculosis (TB) has poor outcomes unless resistance is detected early, ideally by commercially available molecular tests. We present a case of occult multidrug-resistant TB where both rifampicin and isoniazid resistance were missed by molecular testing and were only identified by phenotypic testing.
No takes yet. Share an insight, caveat, or question.
Richards et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: